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Abstract
Highly fluorescent multiblock conjugated polymer nanoparticles with folic acid surface ligands
are highly effective for bioimaging and in vivo tumor targeting. The targeted nanoparticles were
preferentially localized in tumor cells in vivo, thereby illustrating their potential for diagnostic and
therapeutic applications.
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Nanoparticle-based materials have been of significant interest for application in medical
diagnostics and therapeutics.[1] New forms of nanocarriers/nanostructures for drug targeted
delivery and imaging require targeting functions to recognize disease at the cellular level, a
measurable readout (e.g. fluorescent tag, radiolabel) for monitoring uptake and delivery, and
a therapeutic cargo.[1–2] The spectrum of nanostructured materials in this area include
liposomes,[3] micelles,[4] polymer-drug conjugates,[5] dendrimers,[6] carbon nanotubes,[7]
and quantum dots.[8] In vivo imaging and diagnostics is dominated by emissive methods and
small-molecule dyes[9] and semiconductor nanocrystals[10] have emerged as the mostly
widely used emissive probes for bioimaging. Materials with the most utility emit light in far-
red or near-infrared (NIR) emission regions (650–1000 nm), which is characterized by
minimal tissue autofluorescence and reduced scattering.[11] Several strategies have been
developed to incorporate fluorescent dyes or drugs into nanostructures, including
encapsulation of small-molecule dyes or covalent attachment to the particle.[12] The non-
covalent encapsulation is limited by out-diffusion of the small-molecule dye, resulting in an
inability to maintain complete co-localization of the fluorescent tracker with the
nanostructure of interest. Furthermore, only a limited number of small-molecule dyes/or
drugs can be covalently attached to the surface of the carrier system without significantly
altering the carrier’s physicochemical properties, such as the hydrophilicity of the polymer
surface. Alternatively, covalent assembly of the dye within the nanostructures core often
requires tedious synthetic efforts. Although liposomes and polymer-conjugates are among
the most promising nanostructure materials for theranostics and account for the majority of
clinically approved products,[1–5] there are still some drawbacks to their applications
including the limited ability to encapsulate high loading of hydrophobic molecules, early
burst of release of drugs, and moderate circulation half-life in vivo of polymer-conjugates.
Thus, a new class of polymer nanostructures and modular designs that can combine a highly
fluorescent probe and biomolecules for targeted therapeutic delivery using simple covalent
assembly are needed to advance in vivo applications, particularly a platform that can allow
for some degree of independent tuning of optical properties, targeting agents, and
nanoparticle size.
Conjugated polymer nanoparticles (NPs)[13] are an emerging class of emissive materials for
in vivo imaging, tumor targeting, and drug delivery.[14] Nanoparticles based on π-
conjugated polymers are particularly attractive as a result of their high extinction
coefficients, high fluorescence quantum yields, robust photostability, and the ease of
functionalization with biomolecules and targeting ligands. Few classes of conjugated
polymers have been studied for bioimaging including poly(p-phenyleneethynylene)
(PPE),[15] poly(fluorene-co-phenylene),[14b, 16] and poly(benzothiadiazole)[17] and these
materials have mainly been limited to in vitro applications. Most often, the conjugated
polymers are functionalized with ionic side-chains such as carboxylate, sulfate and
quaternary ammonium groups to ensure solubility in water and to facilitate interactions with
biomolecules and cells.[14, 16] However, it is possible for some ionic side-chains to lead to
non-specific interactions with cells and tissues. Recent in vivo studies using
poly(benzothidadiazoles)[18] and poly(p-phenylenevinylene)[19] as a targeted fluorescent
probe have been reported, however in these cases functionalization is achieved via less
robust non-covalent surface modification.
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We report herein highly fluorescent multiblock conjugated polymer nanoparticles (NPs) for
bioimaging and in vivo tumor targeting. The conjugated polymer nanoparticles consist of a
pentablock copolymer of an “ABCBA” structure, where the “C” block is a farred emitting
conjugated polymer, the “A” block contains oligo(ethylene glycol)s to provide water
solubility and promotes both stealth-like and an anti-fouling properties[20] needed for in vivo
applications, and the “B” block contains reactive functionality to incorporate targeting
ligands and therapeutics for tumor targeting and potentially drug payloads (Figure 1). This
design is ideal for targeted drug delivery applications with a central hydrophobic to
accommodate high loading of fluorescent dyes and conventional therapeutics. The outer
layers consist of a hydrophilic biocompatible shell that can be functionalized with ligands/
receptors for cellular recognition. Folate-receptors[21] are overexpressed on the cell
membranes of many gynecologic cancer cell,[22] including ovarian cancer, thus we chose to
functionalize the “B” block with folic acid to target the NPs.
Our nanoparticle designs leverage a similar pentablock copolymer structure that was used
for the detection of proteases by a strain release mechanism.[23] We have similarly inserted
perylene monoimide (PMI) randomly into the PPE backbone in 0.5 and 5 mol % simply by
controlling the stoichiometry of the Songoshira cross-coupling polymerization. PPE-PMI
copolymers were end-capped with norbornadiene[24] (NB-(PPE-PMI)-NB) to allow for
further functionalization with olefin metathesis (Figure 1a). Separately, living diblock
copolymers comprised of norbornene monomers with pendant oligoethyleneglycol (OEG)
(A block) and N-hydroxysuccinate esters (NHS) (B block) were synthesized using ring
opening olefin metathesis polymerization (ROMP) and then terminated by reaction with the
NB-(PPE-PMI)-NB to create ABCBA-pentablock copolymers (Figure 1b). Based on 1H
NMR and gel permeation chromatography (GPC) the degree of polymerization for the OEG,
NHS, and PPE-PMI blocks were 84, 140, and 79, respectively (Supporting Information
(SI)). Finally, the OEG-NHS-(PPE-PMI)-NHS-OEG copolymers were functionalized with
folic acid by attaching 20 or 50 mol % of amine terminated folate to convert the NHS esters
to the corresponding amides, yielding 44 or 104 folate groups on average per polymer chain.
The polymer nanoparticles were prepared by a solvent-exchange method, wherein the
conjugated polymers were initially dissolved in tetrahydrofuran (THF) or N,N-
dimethylformamide (DMF) and then slowly added via syringe under sonication into a vial
containing distilled water (15 mL) (Figure 1c). Absorption spectra of the NB-PPE-PMI-NB
NPs in solution show peak extinction coefficients at (2.6–3.8) × 104 M−1 cm−1 per repeat
unit (Figure S2, SI). The PL spectra display two peaks, a high-energy peak at 454 nm that
can be attributed to the PPE backbone and a dominant low-energy peak which can be
assigned to PMI (Figure 2a). A photograph of the NB-(PPE-PMI)-NB NPs emission under
UV illumination is shown in Figure 2a (inset). Excitation of the PPE backbone at 410 nm
produces a dominant emission at 604 nm from the PMI confirming efficient energy transfer
in the NPs. The energy transfer efficiency can be determined by measuring the ratio of the
fluorescence intensity emitted from the PMI relative to the total emission of the
nanoparticles and was found to be 91 and 97% for NB-(PPE-PMI0.005)-NB and NB-(PPE-
PMI0.05)-NB, respectively. The fluorescence quantum yields (QY) of the nanoparticles
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(relative to Coumarin 6, QY= 0.78) was determined to be 0.26 and 0.14 for NB-(PPE-
PMI0.005)-NB and NB-(PPE-PMI0.05)-NB, respectively.
We characterized the size of the NB-(PPE-PMI)-NB nanoparticles using transmission
electron microscopy (TEM) and dynamic light scattering (DLS). From the TEM images
shown in Figure 2b and DLS measurements (Figure S3a), it was determined that NB-(PPE-
PMI0.005)-NB NPs have a hydrodynamic diameter of 4 nm and have relatively high
uniformity. The relatively high uniformity of NB-(PPE-PMI0.005)-NB NPs can be attributed
in part to filtering the NPs through a membrane filter (0.45 μm). In contrast, NPs made from
NB-(PPE-PMI0.05)-NB are relatively more polydisperse and show two populations with
mean diameter of 28 and 264 nm, as seen from Figure 2c and DLS data (Figure S3b). The
size of the NPs will significantly impact the pharmacokinetics[25] and cellular
internalization[12] of targeted agents; as a result we endeavored to vary the size of the NPs
by changing the polymer concentration in THF or DMF. Increases in the size of the NPs
from 25 to 200 nm were observed, as the concentration of NB-(PPE-PMI0.05)-NB in THF
solution was increased from 50 to 200 μg/mL (Figure S4, SI). The optimum size NPs for
biological applications (80–200 nm) were achieved from a polymer solution concentration
of 70 μg/mL. We find that a similar concentration of OEG-NHS-(PPE-PMI0.005)-NHS-
OEG, OEG-NHS-(PPE-PMI0.05)-NHS-OEG yields NPs in the size range of 10–200 nm
(Figure S5, SI).
Folate-functionalized nanoparticles (OEG-FA-(PPE-PMI0.005)-FA-OEG, OEG-FA-(PPE-
PMI0.05)-FA-OEG) were prepared to evaluate the binding and targeting of the conjugated
polymer NPs to KB cells, which overexpress folate receptors. Live KB cells were incubated
with non-functionalized (OEG-NHS-(PPE-PMI0.005)-NHS-OEG, OEG-NHS-(PPE-
PMI0.05)-NHS-OEG) nanoparticles for 8 hours and confocal microscopy reveals (Figure 3)
that folate NPs (OEG-FA-(PPE-PMI0.005)-FA-OEG, OEG-FA-(PPE-PMI0.05)-FA-OEG) are
selectively taken up as revealed by the red fluorescence (Figure 3f). KB cells were also
stained with Alexa 488 Phalloidin actin stain (Figure 3a, d) and a Hoescht nuclei stain
(Figure 3b, e), which display green and blue fluorescence, respectively. Cells that were
incubated with non-functionalized conjugated polymer nanoparticles (OEG-NHS-(PPE-
PMI0.005)-NHS-OEG and OEG-NHS-(PPE-PMI0.05)-NHS-OEG) show very weak red
emission, consistent with much smaller uptake of NPs (Figure 3c and Figure S6c). The
enhanced cellular uptake of folate-functionalized polymer NPs is clear (Figure 3f and Figure
S6f) and suggest that the NPs are internalized by KB cells. Interestingly, both the non-
functionalized and functionalized particles were observed to primarily localize in the
nucleus. From these data, it appears that the unique pentablock copolymers present future
opportunities in gene delivery.
To examine cell-associated fluorescence, flow cytometry was used to further probe the
targeting capabilities of the conjugated polymer NPs to KB cells (Figure 3g, Figures S7,
S8a). After incubation of KB cells with different NP formulations for eight hours, significant
associations of particles with the cells were observed for the targeted nanoparticles.
Pentablock copolymers containing 5% dye (OEG-NHS-(PPE-PMI0.05)-NHS-OEG, OEG-
FA-(PPE-PMI0.05)-FA-OEG) showed higher cell associated fluorescence compared to the
one containing 0.5% dye (OEG-NHS-(PPE-PMI0.005)-NHS-OEG, OEG-FA-(PPE-
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PMI0.005)-FA-OEG), which is due to the efficient energy transfer observed for those
polymers. Internalization of folate-functionalized NPs in cancer cells appeared to be about 3
to 6-fold higher as compared to non-functionalized NPs (Figure 3g). The highest cell
associated fluorescence was observed for cells incubated with the OEG-20%FA-(PPE-
PMI0.05)-20%FA-OEG. Consistent with confocal microscopy, the non-functionalized NPs
also associated with the cells, however to a lesser extent, likely due to non-specific
endocytotic interactions with the cell.
The inherent cytotoxicity of folate functionalized NPs (OEG-FA-(PPE-PMI0.005)-FA-OEG,
OEG-FA-(PPE-PMI0.05)-FA-OEG) and the non-functionalized NPs (OEG-NHS-(PPE-
PMI0.005)-NHS-OEG, OEG-NHS-(PPE-PMI0.05)-NHS-OEG) was investigated using the 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) viability assay. Both,
the non-functionalized and functionalized NPs show negligible cytotoxicity after an
incubation period of 24 to 48 h with KB cells at a concentration of 20 μg/mL (Figure 3h).
Similar concentrations were consistently used for all in vitro and in vivo experiments. At
higher concentrations, significant toxicity was observed only for the non-functionalized
(OEG-NHS-(PPE-PMI0.005)-NHS-OEG, OEG-NHS-(PPE-PMI0.05)-NHS-OEG)
nanoparticles, likely due to the high reactivity of NHS-ester group in aqueous medium
leading to unfavorable interactions with cells (Figure S8b). The stability of the nanoparticles
in serum was also investigated by temporally-resolved dynamic light scattering. Both
functionalized and non-functionalized nanoparticles did not show significant change in their
hydrodynamic diameter, suggesting minimum aggregation of the nanoparticles in the
presence of serum (Figure S9).
The non-functionalized conjugated polymer NPs (NB-(PPE-PMI0.005)-NB, NB-(PPE-
PMI0.05)-NB, OEG-NHS-(PPE-PMI0.005)-NHS-OEG, OEG-NHS-(PPE-PMI0.05)-NHS-
OEG) were systemically administered into nude mice via a tail vein injection for live-animal
imaging and tracking. In vivo fluorescence images were captured with a 3D optical imaging
system (Caliper Life Sciences) up to 8 days post-injection. Figure 4 shows the NPs persist in
the animal for an extended period of time, ~8 d, after which the level of quantifiable
fluorescence (in units of radiant efficiency) returns to baseline autofluorescence. The
extended circulation of the NPs in the animal (8 d) is remarkable particularly since most
PEGylated micelle systems have moderate half-life of 2–48 h post-injection.[20, 26–27] The
prolonged persistence of the NPs is expected to sufficiently facilitate their delivery to a site
of interest.[28] Tissue harvesting of clearance organs, conducted 24 h post-injection, show
minimal accumulation in vital organs and the majority of NPs accumulate in the GI tract and
the bladder (Figure S10), consistent with the 3D optical live animal imaging (Figure 4).
Together, the biodistribution, the 3D optical imaging, and tissue harvesting of the relevant
organs (Figures 4, 5, S10), suggest that these nanoparticles are cleared from the body
through the processes typically observed with nanoparticle systems, through the liver and
via excretion. The results show that the conjugated polymer NPs traffic in the animal for a
relatively long period of time with no apparent toxicity or undesirable accumulation in the
animal, and underline the advantage of the NPs for targeted bioimaging and drug delivery.
We evaluated the tumor targeting strategy in vivo by delivering two different formulations of
folate functionalized conjugated polymer NPs (OEG-50%FA-(PPE-PMI0.005)-50%FA-OEG
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and OEG-20%FA-(PPE-PMI0.05)-20%FA-OEG) to nude mice bearing KB tumors (Figure
5a). KB xenografts were seeded in both hind flanks and allowed to grow for ~ 2 weeks until
they reached approximately a size of 200 mm3. The NPs were tail vein injected and
monitored using in vivo imaging at an excitation of 405 nm and emission of 620 nm. Figure
5a shows the results from imaging at 24 h after injection of the NPs. Though some
localization is observed, visualization of the nanoparticles by in vivo imaging was difficult
to observe above tissue autofluorescence, likely due to the large amount of light scattered
and absorbed by blood and tissue at the excitation wavelength (λex = 405 nm). Tissue
harvesting of the relevant clearance organs and tumors was conducted 24 h post-injection.
The majority of the recovered fluorescence of the NPs was observed in the tumor as
revealed by 3D optical imaging of harvested tissue (Figure 5b), which is also reflected in
quantification of total radiant efficiency above the untreated control (for autofluorescence
determination). In particular, relatively low accumulation in the liver (25%) and spleen
(15%) was observed in these nanoparticle systems in comparison with PEGylated
nanoparticles[27] and liposomes where accumulation in the liver can exceed 50%. The
biodistribution results of the targeted NPs are also in agreement with the non-functionalized
NPs, where little accumulation is observed in the liver and spleen (Figure S10). Tumor-
specific accumulation was further investigated by sectioning the tumor and employing
confocal microscopy to visualize NP localization in the tissue. Figure 5c shows the KB
tumor morphology under optical microscopy stained with H&E stain (left) and an unstained
tumor (right) section under the fluorescent microscope. The red fluorescence (λex = 405 nm,
λem = 650/50 nm) seen in an unstained tumor section (Figure 5c (right)) clearly illustrates
that the folate functionalized conjugated polymer NPs accumulates effectively in the tumor,
consistent with the 3D optical imaging of harvested organs. These results demonstrate that
systemically-administered targeted conjugated polymer NPs were able to substantially and
preferentially localize in tumor cells in vivo.
In conclusion, we have developed highly fluorescent multiblock conjugated polymer
nanoparticles for bioimaging and in vivo tumor targeting. Our design utilizes simple
synthetic strategies that covalently link conjugated polymers as the emissive dye and
targeting moieties to create multicomponent nanostructures. We have shown that folate
functionalized conjugated polymer nanoparticles exhibit significant cell-associated
fluorescence in vitro compared to non-functionalized NPs. Further, these conjugated
polymer NPs show no inherent cytotoxicity. In vivo studies using 3D optical imaging reveal
that the NPs persist in the animal for extended periods of time with no apparent toxicity or
undesirable accumulation of the NPs in the animal. We demonstrated that systemically-
administered targeted conjugated polymer NPs in vivo can preferentially localize in tumor
cells. These results clearly illustrate that our design of using multiblock copolymers is a
viable approach for bioimaging and in vivo tumor targeting. Optimizations of the CPs core
to extend the emission of the dye to far-red and NIR regions (700–900 nm) to enhance the
apparent sensitivity of animal imaging to NPs (via reduced autofluorescence at the selected
fluorescent channel) are underway. Further incorporation of therapeutic agents will be
investigated to develop conjugated polymer NPs as a systemic delivery agent, in addition to
an imaging modality.
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Molecular structure of a) NB-(PPE-PMI)-NB, b) OEG-NHS-(PPE-PMI)-NHS-OEG and OEG-FA-(PPE-PMI)-FA-OEG, c)
preparation of folate-functionalized nanoparticles.
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a) Photoluminescene spectra of conjugated polymers in THF solution and NB-(PPE-PMI)-NB nanoparticles dispersed in water.
b) A photograph of nanoparticle dispersions with different PMI/PPE ratios (mol%) under UV illumination.
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Confocal microscopy images of live KB cells treated with non-functionalized (a–c) and folate-functionalized nanoparticles
viewed with different filter overlays for: (a, d) stained with Alexa 488 Phalloidin actin and with Hoescht nuclei stain;; (b, e)
showing only Hoescht nuclei stain; (c) nanoparticle fluorescence for OEG-NHS-(PPE-PMI0.005)-NHS-OEG; and (f) treated with
OEG-FA-(PPE-PMI0.005)-FA-OEG. Scale bar: 20 μm. g) Measured mean cell-associated fluorescence of KB cells after 8 h. h)
KB cell viability with different NPs formulation for 24 and 48 h. (0.5% NHS = OEG-NHS-(PPE-PMI0.005)-NHS-OEG; 0.5%
20%FA = OEG-20%FA-(PPE-PMI0.005)-20%FA-OEG; 5% NHS = OEG-NHS-(PPE-PMI0.05)-NHS-OEG; 5% 20%FA =
OEG-20%FA-(PPE-PMI0.05)-20%FA-OEG; control = untreated KB cells).
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Fluorescence 3D optical imaging of nude mice monitored for 10 days post-injection with different conjugated polymer NPs
formulations.
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a) Fluorescence 3D optical imaging of tumor-bearing nude mice at 24 h after injection with folate functionalized conjugated
polymer NPs showing accumulation in tumor tissues. b) Fluorescence 3D optical imaging of harvested organs/tumors at 24 h
post-injection of the functionalized NPs and recovered fluorescence in organs/tumors measured in total radiant efficiency.
Confocal optical microscopy of tumor cells: c) H&E stain (left), unstained fluorescence micrograph (right) of tumor section (λex
= 405 nm, λem = 650/50 nm). Li = liver, Sp = spleen, K = kidney, Lu = lungs, H = heart, T = tumor.
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